Akero Therapeutics said Tuesday that an experimental medicine failed to show a s...
New research shows how AI models can become a victim of their own success, sendi...
The state of Connecticut expects to spend more than $30 million on GLP-1s in 202...
Learning the hard way how to live with a rare inherited immunodeficiency, chroni...
Despite advances in prevention, stroke deaths are projected to near 10 million g...
Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics fr...
The FDA rejected an Alnylam therapy for an increasingly prevalent heart disease,...
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches...
STAT spoke with the global head of Boehringer Ingelheim's innovation unit, about...
Amgen has acquired Ireland-based biotechnology company Horizon Therapeutics in ...
The US is known for having higher list prices for drugs than other high-income ...
The US Food and Drug Administration (FDA) has approved an intravenous (IV) vers...
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on M...
GSK and Chongqing Zhifei Biological Products (Zhifei) have signed an exclusive ...
In recent years, the US has made major strides in the treatment landscape for t...
Ultimovacs has received an orphan drug designation from the US Food and Drug Ad...
